Organization
Robert Bok
3 clinical trials
Clinical trial
A Phase 2 Study of Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer Undergoing Radiation TherapyStatus: Not yet recruiting, Estimated PCD: 2028-09-30
Clinical trial
A Phase I/II Study of Hyperpolarized 13C Pyruvate as a Biomarker of Aggressiveness & Response to Therapy in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-01-31
Clinical trial
Hyperpolarized Carbon-13 Alpha-ketoglutarate Metabolic Imaging in IDH Mutant GliomaStatus: Recruiting, Estimated PCD: 2026-04-30